| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | SVP, Drug Development
1 company
Rosenbaum David P. is a Chief Development Officer at ARDELYX, INC.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2019 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 6,386 | $1.70 | $10,865.78 | -3.5% | |
| Nov 13, 2018 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 5,570 | $2.84 | $15,818.80 | -3.3% | |
| Apr 18, 2017 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 2,051 | $11.98 | $24,577.34 | -4.9% | |
| Mar 10, 2017 | ARDX Ardelyx, Inc. | SVP, Drug Development | Sell | 1,000 | $13.48 | $13,482.30 | -43.9% | |
| Dec 16, 2016 | ARDX Ardelyx, Inc. | SVP, Drug Development | Sell | 900 | $14.48 | $13,035.33 | -58.6% | |
| Mar 3, 2016 | ARDX Ardelyx, Inc. | SVP, Drug Development | Sell | 1,128 | $10.74 | $12,109.87 | -4.8% | |
| Sep 22, 2015 | ARDX Ardelyx, Inc. | SVP, Drug Development | Sell | 1,400 | $22.05 | $30,874.00 | -0.9% | |
| Sep 15, 2015 | ARDX Ardelyx, Inc. | SVP, Drug Development | Sell | 2,540 | $22.01 | $55,897.53 | -3.3% | |
| Sep 3, 2015 | ARDX Ardelyx, Inc. | SVP, Drug Development | Sell | 2,537 | $18.78 | $47,641.27 | -8.9% | |
| Jul 30, 2015 | ARDX Ardelyx, Inc. | SVP, Drug Development | Sell | 2,011 | $19.27 | $38,755.19 | -2.6% |